- Etomidate
- Flumazenil
- Etifoxine hydrochloride
Acamprosate calciumGABA receptor agonist and modulator of glutamatergic systems |
Sample solution is provided at 25 µL, 10mM.
Quality Control & MSDS
- View current batch:
- Purity = 99.78%
- COA (Certificate Of Analysis)
- HPLC
- NMR (Nuclear Magnetic Resonance)
- MSDS (Material Safety Data Sheet)
- Datasheet
Chemical structure
Acamprosate calcium Dilution Calculator
calculate
Acamprosate calcium Molarity Calculator
calculate
Cas No. | 77337-73-6 | SDF | Download SDF |
Synonyms | Calcium N-acetylhomotaurinate; Campral EC | ||
Chemical Name | calcium;3-acetamidopropane-1-sulfonate | ||
Canonical SMILES | CC(=O)NCCCS(=O)(=O)[O-].CC(=O)NCCCS(=O)(=O)[O-].[Ca+2] | ||
Formula | C10H20CaN2O8S2 | M.Wt | 400.48 |
Solubility | <2.45 mg/ml="" in="" dmso,="">2.45><2.64 mg/ml="" in="" etoh,="" ≥40="" mg/ml="" in="" h2o="">2.64> | Storage | Store at -20°C |
Physical Appearance | A solid | Shipping Condition | Evaluation sample solution : ship with blue ice.All other available size:ship with RT , or blue ice upon request |
General tips | For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months. |
Acamprosate calcium is a synthetic drug for abstinence of patients with alcohol dependence [1].
Acamprosate administration can reduce alcohol intake. In rat model, oral acamprosate at dose of 50 to 400 mg/kg/day reduced voluntary oral ethanol consumption dose-dependently. However, the exact cellular target and mechanism of acamprosate is not clear. Acamprosate has a structure similar to that of GABA. It can specifically bind to GABAB receptors but not GABAA receptors. Besides that, acamprosate showed serotonergic properties. It increased 5-HT levels and the effects caused by 5-HT in rats exposed to ethanolvapour. Moreover, acamprosate was thought to have effects on inhibiting the excitatory activity of aminoacid and reducing Ca2+fluxes [1].
References:1.Wilde M I, Wagstaff A J. Acamprosate. Drugs, 1997, 53(6): 1038-1053.